[go: up one dir, main page]

WO2002099116A8 - Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation - Google Patents

Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation

Info

Publication number
WO2002099116A8
WO2002099116A8 PCT/US2002/017428 US0217428W WO02099116A8 WO 2002099116 A8 WO2002099116 A8 WO 2002099116A8 US 0217428 W US0217428 W US 0217428W WO 02099116 A8 WO02099116 A8 WO 02099116A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
methods
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/017428
Other languages
English (en)
Other versions
WO2002099116A2 (fr
WO2002099116A3 (fr
Inventor
David W Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/162,335 external-priority patent/US7034132B2/en
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority to EP02739617A priority Critical patent/EP1401858A4/fr
Priority to CA002448073A priority patent/CA2448073A1/fr
Publication of WO2002099116A2 publication Critical patent/WO2002099116A2/fr
Publication of WO2002099116A8 publication Critical patent/WO2002099116A8/fr
Publication of WO2002099116A3 publication Critical patent/WO2002099116A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des séquences d'acide nucléique codant des polypeptides récepteurs couplés à la protéine G. L'invention concerne également des polypeptides codés par ces séquences d'acide nucléique et sur des anticorps qui se lient de manière immunospécifique à ce polypeptide, ainsi que sur des dérivés, des variants, des mutants, ou des fragments du polypeptide, du polynucléotide ou de l'anticorps précités. L'invention concerne enfin des procédés thérapeutique, diagnostique et de recherche destinés au diagnostic, au traitement et la prévention de troubles dans lesquels interviennent l'un quelconque de ces nouveaux acides nucléiques et de ces nouvelles protéines humaines.
PCT/US2002/017428 2001-06-04 2002-06-04 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation Ceased WO2002099116A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02739617A EP1401858A4 (fr) 2001-06-04 2002-06-04 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
CA002448073A CA2448073A1 (fr) 2001-06-04 2002-06-04 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation

Applications Claiming Priority (38)

Application Number Priority Date Filing Date Title
US29560701P 2001-06-04 2001-06-04
US29566101P 2001-06-04 2001-06-04
US60/295,661 2001-06-04
US60/295,607 2001-06-04
US29641801P 2001-06-06 2001-06-06
US29640401P 2001-06-06 2001-06-06
US60/296,404 2001-06-06
US60/296,418 2001-06-06
US29828501P 2001-06-14 2001-06-14
US60/298,285 2001-06-14
US29855601P 2001-06-15 2001-06-15
US60/298,556 2001-06-15
US29994901P 2001-06-21 2001-06-21
US60/299,949 2001-06-21
US30088301P 2001-06-26 2001-06-26
US60/300,883 2001-06-26
US30155001P 2001-06-28 2001-06-28
US60/301,550 2001-06-28
US31197201P 2001-08-13 2001-08-13
US60/311,972 2001-08-13
US31507101P 2001-08-27 2001-08-27
US60/315,071 2001-08-27
US31566001P 2001-08-29 2001-08-29
US60/315,660 2001-08-29
US32229301P 2001-09-14 2001-09-14
US60/322,293 2001-09-14
US32270601P 2001-09-17 2001-09-17
US60/322,706 2001-09-17
US34118601P 2001-12-14 2001-12-14
US60/341,186 2001-12-14
US36118902P 2002-02-28 2002-02-28
US60/361,189 2002-02-28
US36367602P 2002-03-12 2002-03-12
US36367302P 2002-03-12 2002-03-12
US60/363,676 2002-03-12
US60/363,673 2002-03-12
US10/162,335 2002-06-03
US10/162,335 US7034132B2 (en) 2001-06-04 2002-06-03 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Publications (3)

Publication Number Publication Date
WO2002099116A2 WO2002099116A2 (fr) 2002-12-12
WO2002099116A8 true WO2002099116A8 (fr) 2003-09-25
WO2002099116A3 WO2002099116A3 (fr) 2003-11-20

Family

ID=28047119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/017428 Ceased WO2002099116A2 (fr) 2001-06-04 2002-06-04 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation

Country Status (3)

Country Link
EP (1) EP1401858A4 (fr)
CA (1) CA2448073A1 (fr)
WO (1) WO2002099116A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932821B2 (en) 2003-03-19 2015-01-13 Biogen Idec Ma Inc. NOGO receptor binding protein
US9068992B2 (en) 2004-06-24 2015-06-30 Biogen Ma Inc. Screening methods for identifying Sp35 antagonists

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815181B2 (en) 2001-07-09 2004-11-09 Applera Corporation Nucleic acid molecules encoding human secreted hemopexin-related proteins
ES2434470T3 (es) 2005-07-08 2013-12-16 Biogen Idec Ma Inc. Anticuerpos SP35 y usos de éstos
EP2158317B1 (fr) 2007-05-16 2018-03-28 Gene Signal International Sa Médicament anti-tumoral, médicament, composition et leurs utilisations
EP1992694A1 (fr) * 2007-05-16 2008-11-19 Gene Signal International Sa Médicament anti-tumoral, médicament, composition et leurs utilisations
AU2009269099B2 (en) 2008-07-09 2016-03-10 Biogen Ma Inc. Compositions comprising antibodies to LINGO or fragments thereof
AU2013262934B2 (en) 2012-05-14 2018-02-01 Biogen Ma Inc. LINGO-2 antagonists for treatment of conditions involving motor neurons
CA2973266A1 (fr) 2015-01-08 2016-07-14 Biogen Ma Inc. Antagonistes de lingo-1 et leurs utilisations pour le traitement de troubles de demyelinisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951221A (ja) * 1982-09-17 1984-03-24 Eisai Co Ltd 変形性関節症治療剤
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
KR940003653B1 (ko) * 1985-04-05 1994-04-25 상꾜가부시끼가이샤 인체 췌장 엘라스타제의 제조방법
US5212068A (en) * 1985-04-05 1993-05-18 Sankyo Company Limited Human pancreatic elastase
JPH0673456B2 (ja) * 1986-04-26 1994-09-21 三共株式会社 ヒト・膵臓エラスタ−ゼ▲ｉ▼
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
AU7835400A (en) * 1999-09-27 2001-04-30 Scios Inc. Secreted factors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932821B2 (en) 2003-03-19 2015-01-13 Biogen Idec Ma Inc. NOGO receptor binding protein
US9068992B2 (en) 2004-06-24 2015-06-30 Biogen Ma Inc. Screening methods for identifying Sp35 antagonists

Also Published As

Publication number Publication date
EP1401858A4 (fr) 2005-12-21
EP1401858A2 (fr) 2004-03-31
WO2002099116A2 (fr) 2002-12-12
WO2002099116A3 (fr) 2003-11-20
CA2448073A1 (fr) 2002-12-12

Similar Documents

Publication Publication Date Title
WO2002014368A8 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002055705A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2002064791A3 (fr) Proteines et acides nucleiques codant celles-ci
WO2002057453A3 (fr) Polypeptides et acides nucleiques codant ces derniers
WO2002068649A3 (fr) Proteines et acides nucleiques les codant
WO2002057450A3 (fr) Proteines et acides nucleiques les codant
WO2002068652A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2004015060A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
WO2002081518A3 (fr) Proteines, polynucleotides les codant et leurs procedes d'utilisation
WO2001081578A3 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
WO2002081510A3 (fr) Proteines, polynucleotides codant pour celles-ci et methodes d'utilisation
WO2002016599A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2002046229A3 (fr) Nouvelles proteines et acides nucleiques codant celles-ci
WO2002029038A3 (fr) Nouvelles proteines, acides nucleiques codant ces derniers et anticorps diriges contre ces proteines
WO2002055704A3 (fr) Proteines, polynucleotides codant pour elles et procedes d'utilisation correspondants
WO2002079398A3 (fr) Polypeptides therapeutiques, les acides nucleiques les codant et leurs procedes d'utilisation
WO2002010216A3 (fr) Nouvelles proteines et acides nucleiques codant pour elles
WO2001074904A3 (fr) Nouvelles proteines et acides nucleiques codant pour celles-ci
WO2002055702A3 (fr) Protéines humaines, polynucléotides les codant et procédés d'utilisation correspondants
WO2001066747A3 (fr) Nouvelles proteines et acides nucleiques codant lesdites proteines
WO2002099116A8 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
WO2001074851A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002083841A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation
WO2002026826A3 (fr) Nouvelles proteines et acides nucleiques codant pour celles-ci
WO2002068647A3 (fr) Proteines, polynucleotides codant ces proteines et procedes d'utilisation correspondants

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 50/2002 UNDER (30) REPLACE "60/295,404, 6 JUNE 2001 (06.06.2001), US" BY "60/296,404, 6 JUNE 2001 (06.06.2001), US" AND 60/261,189, 28 FEBRUARY 2002 (28.02.2002), US" BY 60/361,189, 28 FEBRUARY 2002 (28.02.2002), US" AND "NOT FURNISHED" BY "10/162,335"

WWE Wipo information: entry into national phase

Ref document number: 2002312258

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2448073

Country of ref document: CA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002739617

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002739617

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2002739617

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP